Plasma F2-isoprostane class VI isomers at 12-18 weeks of pregnancy are associated with later occurrence of preeclampsia

Free Radical Biology and Medicine

Volumn 85, Issue , 2015, Pages 282-287

  Bilodeau, Jean François ^a,b   Qin Wei, Shu ^c   Larose, Jessica ^a   Greffard, Karine ^a,b   Moisan, Vanessa ^a   Audibert, Francois ^c   Fraser, William D ^c   Julien, Pierre ^a,b  

^a University Laval   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Isoprostanes; Mass spectrometry; Oxidativestress; Polyunsaturatedfattyacids; Preeclampsia; Pregnancy

Indexed keywords

ISOPROSTANE DERIVATIVE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; UNSATURATED FATTY ACID;

ARTICLE; BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROLYSIS; ISOMER; LIQUID LIQUID EXTRACTION; MAJOR CLINICAL STUDY; PHOSPHOLIPID BLOOD LEVEL; PLASMA VOLUME; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; BLOOD; COHORT ANALYSIS; ISOMERISM; RISK FACTOR; SECOND TRIMESTER PREGNANCY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; F2-ISOPROSTANES; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; ISOMERISM; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RISK FACTORS; TANDEM MASS SPECTROMETRY;

EID: 84934926971     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.05.012     Document Type: Article

References (28)

1. J.F. Bilodeau Review: Maternal and placental antioxidant response to preeclampsia - Impact on vasoactive eicosanoids Placenta 35S 2014 S32 S38
2. J. Larose, P. Julien, K. Greffard, W.D. Fraser, F. Audibert, S.Q. Wei, and J.F. Bilodeau F2-isoprostanes are correlated with trans fatty acids in the plasma of pregnant women Prostaglandins, leukotrienes, and essential fatty acids 91 2014 243 249
3. G.L. Milne, Q. Dai, and L.J. Roberts 2nd The isoprostanes-25 years later Biochimica et biophysica acta 2014
4. W.L. Song, G. Paschos, S. Fries, M.P. Reilly, Y. Yu, J. Rokach, C.T. Chang, P. Patel, J.A. Lawson, and G.A. Fitzgerald Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation J Biol Chem 284 2009 23636 23643
5. J.M. Proudfoot, A.E. Barden, W.M. Loke, K.D. Croft, I.B. Puddey, and T.A. Mori HDL is the major lipoprotein carrier of plasma F2-isoprostanes J Lipid Res 50 2009 716 722
6. D.F. Taber, J.D. Morrow, and L.J. Roberts 2nd A nomenclature system for the isoprostanes Prostaglandins 53 1997 63 67
7. J. Rokach, S.P. Khanapure, S.W. Hwang, M. Adiyaman, J.A. Lawson, and G.A. FitzGerald Nomenclature of isoprostanes: a proposal Prostaglandins 54 1997 853 873
8. S.M. Bode-Boger, R.H. Boger, M. Kuhn, J. Radermacher, and J.C. Frolich Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids Kidney international 50 1996 1255 1261
9. P.M. Aristegui, and M.A. Enero Endothelium and Ca2+ in the prostaglandin F2 alpha potentiation of vasoconstrictor responses Eur J Pharmacol 184 1990 1 7
10. J. Larose, P. Julien, and J.F. Bilodeau Analysis of F2-isoprostanes in plasma of pregnant women by HPLC-MS/MS using a column packed with core-shell particles J Lipid Res 54 2013 1505 1511
11. T.O. Scholl, M. Leskiw, X. Chen, M. Sims, and T.P. Stein Oxidative stress, diet, and the etiology of preeclampsia Am J Clin Nutr 81 2005 1390 1396
12. E.T. McKinney, R. Shouri, R.S. Hunt, R.A. Ahokas, and B.M. Sibai Plasma, urinary, and salivary 8-epi-prostaglandin f2alpha levels in normotensive and preeclamptic pregnancies Am J Obstet Gynecol 183 2000 874 877
13. C.N. Wang, J.Y. Chen, S. Sabu, Y.L. Chang, S.D. Chang, C.C. Kao, H.H. Peng, H.Y. Chueh, A.S. Chao, P.J. Cheng, Y.S. Lee, L.M. Chi, and T.H. Wang Elevated amniotic fluid F(2)-isoprostane: a potential predictive marker for preeclampsia Free Radic Biol Med 50 2011 1124 1130
14. S.Q. Wei, F. Audibert, N. Hidiroglou, K. Sarafin, P. Julien, Y. Wu, Z.C. Luo, and W.D. Fraser Longitudinal vitamin D status in pregnancy and the risk of pre-eclampsia BJOG: an international journal of obstetrics and gynaecology 119 2012 832 839
15. M.E. Helewa, R.F. Burrows, J. Smith, K. Williams, P. Brain, and S.W. Rabkin Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy Canadian Medical Association journal 157 1997 715 725
16. D. Raymond, and E. Peterson A critical review of early-onset and late-onset preeclampsia Obstetrical & gynecological survey 66 2011 497 506
17. E. Counil, P. Julien, B. Lamarche, M.L. Chateau-Degat, A. Ferland, and E. Dewailly Association between trans-fatty acids in erythrocytes and pro-atherogenic lipid profiles among Canadian Inuit of Nunavik: possible influences of sex and age Br J Nutr 102 2009 766 776
18. C. Viviani Anselmi, C. Ferreri, V. Novelli, R. Roncarati, R. Bronzini, G. Marchese, F. Somalvico, G. Condorelli, A.S. Montenero, and A.A. Puca Fatty acid percentage in erythrocyte membranes of atrial flutter/fibrillation patients and controls Journal of interventional cardiac electrophysiology: an international journal of arrhythmias and pacing 27 2010 95 99
19. N.E. Bastani, T.E. Gundersen, and R. Blomhoff Determination of 8-epi PGF(2alpha) concentrations as a biomarker of oxidative stress using triple-stage liquid chromatography/tandem mass spectrometry Rapid Commun Mass Spectrom 23 2009 2885 2890
20. E. Schwedhelm, and R.H. Boger Application of gas chromatography-mass spectrometry for analysis of isoprostanes: their role in cardiovascular disease Clin Chem Lab Med 41 2003 1552 1561
21. J.M. Morris, N.K. Gopaul, M.J. Endresen, M. Knight, E.A. Linton, S. Dhir, E.E. Anggard, and C.W. Redman Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia Br J Obstet Gynaecol 105 1998 1195 1199
22. I.A. Siddiqui, A. Jaleel, W. Tamimi, and H.M. Al Kadri Role of oxidative stress in the pathogenesis of preeclampsia Arch Gynecol Obstet 282 2010 469 474
23. H. Li, J.A. Lawson, M. Reilly, M. Adiyaman, S.W. Hwang, J. Rokach, and G.A. FitzGerald Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine Proc Natl Acad Sci U S A 96 1999 13381 13386
24. M. Ramezani, F. Nazemian, J. Shamsara, R. Koohrokhi, and A.H. Mohammadpour Effect of omega-3 fatty acids on plasma level of 8-isoprostane in kidney transplant patients Journal of renal nutrition: the official journal of the Council on Renal Nutrition of the National Kidney Foundation 21 2011 196 199
25. E. Mas, R.J. Woodman, V. Burke, I.B. Puddey, L.J. Beilin, T. Durand, and T.A. Mori The omega-3 fatty acids EPA and DHA decrease plasma F(2)-isoprostanes: Results from two placebo-controlled interventions Free Radic Res 44 2010 983 990
26. J. Belik, G.E. Gonzalez-Luis, F. Perez-Vizcaino, and E. Villamor Isoprostanes in fetal and neonatal health and disease Free Radic Biol Med 48 2010 177 188
27. X. Yu, C.S. Ho, and C.W. Lam Biological variation of plasma F2-isoprostane-III and arachidonic acid in healthy individuals Clin Chem 50 2004 1428 1430
28. T.H. Hung, L.M. Lo, T.H. Chiu, M.J. Li, Y.L. Yeh, S.F. Chen, and T.T. Hsieh A longitudinal study of oxidative stress and antioxidant status in women with uncomplicated pregnancies throughout gestation Reprod Sci 17 2010 401 409